The findings could also have major implications for medical research, as differing levels of gene activity may affect one's susceptibility to developing a disease or one's response to a particular drug. The research was conducted at the University of Washington, and was led by Joshua Akey, assistant professor of genome sciences, and John Storey, associate professor of genome sciences and of biostatistics. Their findings appear in the March issue of the American Journal of Human Genetics.
"This is exactly what makes drug development so difficult, or why it's so hard to pinpoint an exact cause for a particular disease," said Akey. "People have so much variation both in their genetic information and in how those genes are activated and regulated. We need to have a much better understanding of human genetic and gene-expression variation in order to better treat complex diseases and develop more effective drugs."
The researchers examined data on thousands of genes from 16 people of European and African ancestry, cataloging the variations between those individuals. They studied each person's levels of gene expression, which measures how much a particular gene is activated during the process of translating DNA into a substance called RNA, and from that into basic proteins. The more a gene is expressed, the more "messenger" RNA is produced, leading to formation of more proteins corresponding to that gene. Those proteins are the building blocks that make up living cells and tissue.
"The difference between ge
Source:University of Washington